That is why the aim of our study was an effort to elucidate and evaluate the utility of selected CXC-chemokines determination (CXCL5, CXCL14 and CXCL16) in patients with colorectal cancer compared to healthy control. This evidence concerns the gene CXCL16 and colorectal cancer.